Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New treatment for chronic constipation in women

  • Comment

Prucalopride (Resolor, Movetis) should be an option for the treatment of chronic constipation in women.

The National Institute for Health and Clinical Excellence has provisionally ruled that women for whom laxatives have failed to provide adequate relief should be given the option of prucalopride.

In draft guidance, NICE stated that prucalopride should only be considered for women who have tried at least two different types of laxatives from different classes – at the highest tolerated recommended doses – for at least six months, but have not had relief from constipation, and invasive treatment is being considered.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.